… cross-matching using a direct comparison of the donor’s HLA typing with the recipient’s
HLA … was determined using the eGFR value at 1 year post-transplant as baseline value. The …

… Comparison of baseline characteristics of included verses … crossmatch. Development of
dnDSA in the highest risk recipients with HLA incompatibility defined by positive crossmatch …

… pretransplant DSA in negative flow crossmatched kidney transplant recipients. Overall, the
… , there was some heterogeneity in the recipient's baseline characteristics as the presence of …

… living donor and when there is a negative CDC-crossmatch. In … outcomes in literature vary,
we hypothesized that the impact of pretransplant DSA in living donor kidney transplantation …

… that kidney transplantation across donor-specific antibodies (… outcomes of 101 HLA
incompatible kidney transplantation (9) … higher ABMR rates in positive baseline CDCXM while …

… patients, 89.5% demonstrated conversion of baseline positive crossmatch to negative
within 24 h after imlifidase treatment. Donor-specific antibodies most often rebounded 3–14 d …

… test (CDC) or flow-cytometric cross-match test 24, 25, while … are unable to assess donor-specific
antibodies, which serve as … However, the incidence of de novo DSA (14%) and baseline …

… A positive complement-dependent cytotoxicity crossmatch (CDC-XM) is … on baseline
MFI values. The target of desensitization was negative conversion in the XM test for XM-positive …

… underwent KT, despite being positive CDC crossmatch and DSA titers >5000 MFI. … outcome
after desensitization in HLA incompatible transplants with positive baseline CDC crossmatch …

… ) pretreatment crossmatch status donor-specific antibody levels … affect outcome: measurements
of baseline sensitization and the … with a positive baseline CDC crossmatch is significantly …